SE203478C1 - - Google Patents

Info

Publication number
SE203478C1
SE203478C1 SE203478DA SE203478C1 SE 203478 C1 SE203478 C1 SE 203478C1 SE 203478D A SE203478D A SE 203478DA SE 203478 C1 SE203478 C1 SE 203478C1
Authority
SE
Sweden
Prior art keywords
ethoxycarbonyl
phenyl
ethanol
piperidino
mixture
Prior art date
Application number
Other languages
Swedish (sv)
Publication date
Publication of SE203478C1 publication Critical patent/SE203478C1/sv

Links

Landscapes

  • Hydrogenated Pyridines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Description

KLASS INTERNATIONELLSVENSK C07 d12 p:1/01 PATENT- OCH REGISTRERINGSVERKET tins. 2310/1958 inkom den 10/3 1958 utlagd den 26/7 196 THE BRITISH DRUG HOUSES LTD, LONDON, STORBRITANNIEN Sift att framstalla vissa i 1-stalltUng substituerade 4-fenyl-piperidinderivat med analgetisk verkan Uppflinnare: V Petrow och 0 Stephenson Prioritet begard fain den 12 mars 1957 (Storbritannien) Denna uppfinning kalif or sig till framstallningen av vissa i 1-st611ning substituerade 4-fenylpiperidinderivat, vilka äïø vardefulla p5 grund av sina analgetiska egenskaper. CLASS INTERNATIONAL SWEDISH C07 d12 p: 1/01 PATENT AND REGISTRATION AGENCY tins. 2310/1958 was received on 10/3 1958 published on 26/7 196 THE BRITISH DRUG HOUSES LTD, LONDON, UNITED KINGDOM Aim to produce certain 1-stable-young substituted 4-phenyl-piperidine derivatives with analgesic effect Inventors: V Petrow and 0 Stephenson Priority requested This invention relates to the preparation of certain 1-position-substituted 4-phenylpiperidine derivatives which are valuable because of their analgesic properties.

Det är kant att piperidinderivat med den all- manna formeln RC6H CO (I) dir R betecknar en lagre alkoxi- eller lagre alkylraclikal innehallande frau 1 till 3 kolatomer och R' betecknar en metylradikal, ha utprdglade analgetiska egenskaper. Det är vidare kant, att de biologiska egenskaperna hos sadana foreningar i stor utstrackning hero pa arten av gruppen R', och att en andring av gruppen R', fran lagre alkyl och isynnerhet metyl i allmanhet leder till en markerad minskning i analgetisk aktivitet. It is true that piperidine derivatives of the general formula RC6H CO (I) dir R represent a lower alkoxy or lower alkyl radical containing from 1 to 3 carbon atoms and R 'represents a methyl radical, having pronounced analgesic properties. It is further known that the biological properties of such compounds largely depend on the nature of the group R ', and that a change in the group R', from lower alkyl and in particular methyl in general leads to a marked decrease in analgesic activity.

Det har nu overraskande visat sig, att man genom ersattning av metylgruppen (R') i f oreningar med ovansthende allmanna forme' I med 3-aryloxi-2-hydroxipropylresten (II) Ar0 • CH, • R2 C(OH). CH,- (II, ddr R2 betecknar irate eller en metylgrupp) erhaller foreningar med analgetisk verkan, vilken t. o. m. kan yam . stone an den hos de motsvarande foreningarna, i vilka R' betecknar en me tylgrupp. It has now surprisingly been found that by replacing the methyl group (R ') in compounds of the above general formula' I with the 3-aryloxy-2-hydroxypropyl radical (II) ArO • CH, • R2 C (OH). CH, - (II, ddr R2 represents irate or a methyl group) obtain compounds with analgesic action, which can even yam. stone an den of the corresponding compounds, in which R 'represents a methyl group.

Uppfinningen avser darfor ett satt att framstalla piperidinderivat med analgetisk verkan, kannetecknat darav, att ett piperidinderivat med formeln omsdttes med en lamplig 3-aryloxi4:2-epoxipropan med den allmanna formeln R2 I 0 I/ \ Ar • 0 - CH, • C--CH, eller med en lamplig 3-aryloxi-2-hydroxipropylklorid med den allmanna formeln 1=1.2 .As0 • CH,. C(OH). CH,. Cl i narvaro av en klorvateacceptor f6r erhallande av ett piperidinderivat med den allmanna formeln R2 Ar0C(OH)•CH2•N C,H, CUR' 2 i vilka formler Ar betecknar en fenyl-, o-, m- eller p-tolyl, o-, m- eller p-metoxifenyl- eller lagre alkoxifenylradikal med 1-6 kolatomer i alkoxigruppen, o-, m- eller p-klorfenyl, o-, m- eller pbromfenyl-, o-, m- eller p-fluorfenyl eller o-, meller p-aminofenylradikal eller acylderivat (Way, betecknar vale eller en metylgrupp och R' betecknar en lagre alkoxi- eller lagre alkylgrupp innehallande 1-3 kolatomer. Klorvateacceptorn kan utgoras av natriumkarbonat eller natriumhydroxid. The invention therefore relates to a process for preparing piperidine derivatives having analgesic action, characterized in that a piperidine derivative of the formula is reacted with a suitable 3-aryloxy4: 2-epoxypropane of the general formula R2 I -CH, or with a suitable 3-aryloxy-2-hydroxypropyl chloride of the general formula 1 = 1.2 .AsO • CH 2. C (OH). CH ,. Cl in the presence of a chlorvate acceptor to give a piperidine derivative of the general formula R2 ArOC (OH) • CH2 • NC, H, CUR '2 in which formulas Ar ,, m- or p-methoxyphenyl or lower alkoxyphenyl radical having 1-6 carbon atoms in the alkoxy group, o-, m- or p-chlorophenyl, o-, m- or p-bromophenyl-, o-, m- or p-fluorophenyl or o -, or p-aminophenyl radical or acyl derivative (Way, denotes vale or a methyl group and R 'denotes a lower alkoxy or lower alkyl group containing 1 to 3 carbon atoms.

Enligt uppfinningen framstalles exempelvis foljande speciella nya foreningar: 1-(4'-etoxikarbonyl-4'-fenyl)piperidino- 3-o -toloxiprop an-2-ol och dess hydroklorid. 1- (4'- etoxikarbonyl- 4' - fenyl) -piperidino - 3 - p - acetamidofenoxipropan-2-ol, 1 (4'-etoxikarb ony1-4'-fenyl)-piperidino-3-p-aminofenmdprop an-2-ol-hydroklorid, 1-(4'- etoxikarbonyl-4'- feny1)-piperidino-3-fenoxipropan-2-ol och salter darav, 1- (4'- etoxikarbonyl-4' -fenyl) -piperidino -3-0 - klorfenoxipropan-2-ol och dess hydroklorid, 1 (4'-etoxikarb ony1-4'-feny1)-piperidino-3-m-tolmd-propan-2-ol och dess hydroklorid, 1- (4'- etoxikarbonyl- 4'-fenyl) -piperidino -3- ptoloxi-propan-2-ol och dess hydroklorid, 1 -(4'- etoxikarbonyl-4' -f enyl) -piperidino -3 -petoxikarbonylfenoxi-propan-2-ol och dess hydroklorid, 1 - (4' - etoxikarbonyl-4' -fenyl) - piperidino - 3 - o - fluorfenoxi-propan-2-ol och dess hydroklorid, 1-(4'-etoxikarbonyl-4'-fenyl) -piperidino - 2 - me - ty1-3-o-tolmd-propan-2-ol-hydroklorid, 1-(4'-etoxikarbony1-4'-feny1)-piperidino-3-o-allylfenoxi-propan-2-ol-hydroldorid, 1- (4' -etoxikarbonyl-4'-fenyl) -piperidino - 3 - mklorfenoxipropan-2-ol och dess hydroklorid, 1 -(4' - etoxikarbonyl- 4'- feny1)- piperidino -3- p - klorfenoxipropan-2-ol och dess hydroklorid, 1- (4' - etoxikarbonyl -4' - feny1)- piperidino- 3- 0metoxifenoxipropan-2-ol och dess hydroklorid samt 1-(4'-etwdkarb ony1-4'-feny1)-piperidino-2-metyl3-fenoxipropan-2-ol-hydroldorid. According to the invention, for example, the following special novel compounds are prepared: 1- (4'-ethoxycarbonyl-4'-phenyl) piperidino-3-o-toloxypropan-2-ol and its hydrochloride. 1- (4'-Ethoxycarbonyl-4 '-phenyl) -piperidino-3-p-acetamidophenoxypropan-2-ol, 1- (4'-ethoxycarbonyl-4'-phenyl) -piperidino-3-p-aminophenodroprop-2 -ol-hydrochloride, 1- (4'-ethoxycarbonyl-4'-phenyl) -piperidino-3-phenoxypropan-2-ol and salts thereof, 1- (4'-ethoxycarbonyl-4'-phenyl) -piperidino-3-ol O-chlorophenoxypropan-2-ol and its hydrochloride, 1- (4'-ethoxycarbonyl-4'-phenyl) -piperidino-3-m-tolimd-propan-2-ol and its hydrochloride, 1- (4'-ethoxycarbonyl- 4'-phenyl) -piperidino-3-petholoxy-propan-2-ol and its hydrochloride, 1- (4'-ethoxycarbonyl-4'-phenyl) -piperidino-3-petoxycarbonylphenoxy-propan-2-ol and its hydrochloride , 1- (4 '- ethoxycarbonyl-4'-phenyl) -piperidino-3-o-fluorophenoxy-propan-2-ol and its hydrochloride, 1- (4'-ethoxycarbonyl-4'-phenyl) -piperidino-2 - Methyl-3-o-toluid-propan-2-ol-hydrochloride, 1- (4'-ethoxycarbonyl-4'-phenyl) -piperidino-3-o-allylphenoxy-propan-2-ol-hydrolide, 1- (4'-ethoxycarbonyl-4'-phenyl) -piperidino-3-chlorophenoxypropan-2-ol and its hydrochloride, 1 - (4 '- ethoxycarbonyl-4'-phenyl) -piperidino-3-p-chlorophenoxypropan-2-ol and its hydrochloride, 1- (4'-ethoxycarbonyl-4'-phenyl) -piperidino-3-methoxyphenoxypropane-2- ol and its hydrochloride and 1- (4'-ethylcarbonyl-4'-phenyl) -piperidino-2-methyl-3-phenoxypropan-2-ol hydrolide.

Vid framstallningen av foreningar, i vilka Ar betecknar o-, m- eller p-aminofenyl, är det onskvart att skydda aminofenylgruppen i mellanprodukterna med de allmanna formlerna IV och VI och att senare aterstalla aminofenylgruppen genom kanda metoder. In the preparation of compounds in which Ar represents o-, m- or p-aminophenyl, it is desirable to protect the aminophenyl group in the intermediates of the general formulas IV and VI and to later restore the aminophenyl group by known methods.

Kondensation av epoxiderna (IV) eller klorhydrinerna (VI) med piperidinbaserna (V) kan astadkommas i franvaro av losningsmedel eller i narvaro av losningsmedel, exempelvis etanol, bensen eller lattpetroleum. De erhallna produkterna kunna isoleras direkt i kristalliniskt tillstand eller ocksa kunna de isoleras genom standardmetoder innefattande fraktionerad destination under nedsatt tryck. Condensation of the epoxides (IV) or chlorohydrins (VI) with the piperidine bases (V) can be effected in the absence of solvents or in the absence of solvents, for example ethanol, benzene or petroleum. The resulting products can be isolated directly in the crystalline state or they can also be isolated by standard methods including fractional distillation under reduced pressure.

Uppfinningen belyses i det fOljande narmare genom nagra exempel pa metoder for genomforande av sattet enligt uppfinningen. The invention is further elucidated in the following by some examples of methods for carrying out the method according to the invention.

Exempel 1. 1-(4'-etoxikarbony1-4'-feny1)-piperidino-3-o-toloxipropan-2-ol (III: Ar = o-tolyl, R2 = H, R' = OEt).— 3-o-toloxi-1:2-epoxipropan (5,7 g) sattes till en losning av 4-etoxikarbonyl-4-fenylpiperidin (8,0 g) i lattpetroleum (10 ml, kokpunkt 60-80°C) och blandningen upphettades under aterflOde pa angbad i 3 timmar. Example 1. 1- (4'-Ethoxycarbonyl-4'-phenyl) -piperidino-3-o-toloxypropan-2-ol (III: Ar = o-tolyl, R2 = H, R '= OEt). o-Toloxy-1: 2-epoxypropane (5.7 g) was added to a solution of 4-ethoxycarbonyl-4-phenylpiperidine (8.0 g) in light petroleum (10 ml, b.p. 60-80 ° C) and the mixture was heated under aterflOde on angbad for 3 hours.

Efter kylning behandlades losningen med ett litet Overskott av en lOsning av klorvategas i etanol. Vid utspadning av den varma losningen med eter erh011s produkten som den kristalliniska hydrokloriden. After cooling, the solution was treated with a small excess of a solution of hydrogen chloride gas in ethanol. Upon dilution of the hot solution with ether, the product is obtained as the crystalline hydrochloride.

Denna renades genom omkristallisering ur etanol, och utskildes ur detta losningsmedel som vita prismaiiska kristaller med smaltpunkten 188-189°C. Hydrokloriden renades aven genom kristallisering ur vatten. This was purified by recrystallization from ethanol, and separated from this solvent as white prismatic crystals, m.p. 188-189 ° C. The hydrochloride was also purified by crystallization from water.

Exempel 2. 1-(4'-etoxikarbony1-4'-feny1)-piperidino-3-p-acetamido-fenoxipropan-2-ol (III: Ar= = p-NHAc.13.2 = H, R' = OEt).— 4-etoxikarbony1-4-fenylpiperidin (20,6 g) sattes till en losning av 1-p-acetarnidofenoxi-2:3-epoxipropan (18,3 g) i 50 ml etanol. En svagt exotermisk reaktion intraffade och nar denna upphort upphettades blandningen pa angbad i 1 timme. Example 2. 1- (4'-Ethoxycarbonyl-4'-phenyl) -piperidino-3-p-acetamido-phenoxypropan-2-ol (III: Ar = = p-NHAc.13.2 = H, R '= OEt). 4-Ethoxycarbonyl-4-phenylpiperidine (20.6 g) was added to a solution of 1-p-acetanidophenoxy-2: 3-epoxypropane (18.3 g) in 50 ml of ethanol. A slight exotherm occurred and when quenched the mixture was heated on a steam bath for 1 hour.

Efter avlagsnande av etanolen stelnade aterstoden. En del av produkten renades genom kristallisering ur etylacetat, varvid den bade en smaltpunkt 141 145°C. 1- (4'- etoxikarbonyl-4' -fenyl) -piperidino - 3 - p - aminofenoxipropan-2-ol-hydroklorid (III: Ar — = p.NH2. C21-14-, R2 = H, R' = 0E4— Ovanstaende acetamidoderivat (20 g) lostes i 50 ml etanol, behandlades med en losning av 8 g klorvatesgas i 50 ml etanol och blandningen upphettades under aterflode i 6 timmar. Efter avlagsnande av den etanoliska klorvatesyran vid reducerat tryck renades det aterstaende fasta materialet genom kristallisering ur en blandning av etanol och etylacetat for erhallande av produkten som sma vita kristaller med en smallpunkt av cirka 230°C (med sonderdelning). After removal of the ethanol, the residue solidified. A portion of the product was purified by crystallization from ethyl acetate, bathing at a melting point of 141 145 ° C. 1- (4'-ethoxycarbonyl-4'-phenyl) -piperidino-3-p-aminophenoxypropan-2-ol hydrochloride (III: Ar - = p.NH2. C21-14-, R2 = H, R '= OE4 The above acetamido derivative (20 g) was dissolved in 50 ml of ethanol, treated with a solution of 8 g of hydrogen chloride gas in 50 ml of ethanol and the mixture was heated under reflux for 6 hours. from a mixture of ethanol and ethyl acetate to give the product as small white crystals with a narrowing point of about 230 ° C (with probe division).

Exempel 3. 1-(4'-etmdkarbony1-4'-feny1)-piperidino-3-fenoxipropan-2-ol. Example 3. 1- (4'-Ethylcarbonyl-4'-phenyl) -piperidino-3-phenoxypropan-2-ol.

En blandning av 4-etox.ikarbony1-4-fenyl-piperidin (8,2 g) och 3-fenoxi-1:2-epoxipropan (5,3 g) i lattpetroleum (20 ml, kokpunkt 60-80° C) upphettades pa angbad i 1 timme. Produkten kristalliserade vid kylning och renades genom kristallisering ur vattenhaltig etanol under bildning av sma skinande nalar med en smaltpunkt av 111°C. A mixture of 4-ethoxycarbonyl-4-phenyl-piperidine (8.2 g) and 3-phenoxy-1: 2-epoxypropane (5.3 g) in light petroleum (20 ml, b.p. 60-80 ° C) was heated pa angbad for 1 hour. The product crystallized on cooling and was purified by crystallization from aqueous ethanol to give small shiny needles with a melting point of 111 ° C.

Den ovannamnda basen omvandlades till hydrokloriden i koncentrerad etanolisk losning. Den senare foreningen kristalliserade ur en blandning 3 av etanol och eter i skinande vita prismer med en smaltpunkt av 178-179°C. The above base was converted to the hydrochloride in concentrated ethanolic solution. The latter compound crystallized from a mixture 3 of ethanol and ether in shiny white prisms with a melting point of 178-179 ° C.

Andra salter av 1-(4'-etoxikarbony1-4'-feny1)- pip eridino-3-fenoxiprop an-2-ol. Other salts of 1- (4'-ethoxycarbonyl- 4'-phenyl) -piperidino-3-phenoxypropan-2-ol.

Hydrobromiden utskildes ur etanol i vita nalar med smaltpunkten 163-164°C. The hydrobromide was separated from ethanol in white needles, m.p. 163-164 ° C.

Det sura sulfatet utskildes ur etanol i kornformiga kristaller med smaltpunkten 181-183°C. Dessa stelnade pa nytt och smalte darefter Ater vid 263-264°C (med sonderdelning). Nar smaltpunkten undersoktes mycket langsamt no terades icke den lagre smaltpunkten. The acid sulfate was separated from ethanol into granular crystals, m.p. 181-183 ° C. These solidified again and then melted again at 263-264 ° C (with probe division). When the melting point was examined very slowly, the lower melting point was not noted.

Divatefosfatet kristalliserade ur vattenhaltig etanol i vita nalar med smaltpunkten 174175°C. The divate phosphate crystallized from aqueous ethanol in white needles, m.p. 174175 ° C.

Hypofosfitet utskildes ur blandningar av etanol och eter i vita nalar med smaltpunkten 114,7-- 116,5°C (korr.). Hypophosphite was separated from mixtures of ethanol and ether in white needles with a melting point of 114.7-116.5 ° C (corr.).

Sulfamatet utskildes ur etanol i sparsamt lasliga kristaller med smaltpunkten 166°C. The sulfamate was precipitated from ethanol in sparingly welded crystals, m.p. 166 ° C.

Glycerofosfatet hade smaltpunkten 153-154°C efter kristallisering ur en blandning av etanol och eter. The glycerophosphate had a melting point of 153-154 ° C after crystallization from a mixture of ethanol and ether.

Metansulfonatet kristalliserade ur etanol i nalar med smaltpunkten 150-151°C. The methanesulfonate crystallized from ethanol in needles, m.p. 150-151 ° C.

Isetionatet erholls som skinande plattor med en smaltpunkt av 131-133°C efter kristallisering ur en blandning av etanol och eter. The isethionate is obtained as shiny plates with a melting point of 131-133 ° C after crystallization from a mixture of ethanol and ether.

Laktatet hade smaltpunkten 132-133°C efter kristallisering ur en blandning av etanol och eter. The lactate had a melting point of 132-133 ° C after crystallization from a mixture of ethanol and ether.

Tartratet utskildes ur vatten innehallande en liten mangd etanol i sma vita nalar med smaltpunkten 137-138°C. The tartrate was separated from water containing a small amount of ethanol in small white needles with a melting point of 137-138 ° C.

Exempel 4. 1-(4'-etoxikarbony1-4'-feny1)-piperidino-3-o-klorfenoxipropan-2-ol. 3-o-klorfenoxi-1:2-epoxipropan (7,1 g) sattes till en %suing av 4-etoxikarbony1-4-fenylpiperidin i lattpetroleum (10 ml, kokpunkt 60-80°C). Blandningen upphettades pa angbad i tva timmar och produkten utskildes vid kylning. Basen renades genom kristallisering ur vattenhaltig etanol och hade smaltpunkten 81-83°C. Hydrokloriden hade smaltpunkten 171-172°C efter kristallisering ur en blandning av etanol och eter. Example 4. 1- (4'-Ethoxycarbonyl-4'-phenyl) -piperidino-3-o-chlorophenoxypropan-2-ol. 3-o-Chlorophenoxy-1: 2-epoxypropane (7.1 g) was added to one% suspension of 4-ethoxycarbonyl-4-phenylpiperidine in light petroleum (10 ml, b.p. 60-80 ° C). The mixture was heated on a steam bath for two hours and the product was separated on cooling. The base was purified by crystallization from aqueous ethanol and had a melting point of 81-83 ° C. The hydrochloride had a melting point of 171-172 ° C after crystallization from a mixture of ethanol and ether.

Exempel 5. 1-(4'-etoxikarbony1-4'-feny1)-piperidino-3-m-toloxipropan-2-ol. Example 5. 1- (4'-Ethoxycarbonyl-4'-phenyl) -piperidino-3-m-toloxypropan-2-ol.

En blandning av 3-m-toloxi-1:2-epoxipropan (8,2 g) och 4-etoxikarbony1-4-fenylpiperidin (11,7 g) i lattpetroleum (15 ml, kokpunkt 60-80°C) upphettades pa angbad i tre timmar. Basen, vilken utskildes vid kylning, renades genom kristallisering ur vattenhaltig etanol eller ur lattpetroleum (kokpunkt 60-80°C) och bildade vita krusiga nalar med smaltpunkten 80-81°C. A mixture of 3-m-toloxy-1: 2-epoxypropane (8.2 g) and 4-ethoxycarbonyl-4-phenylpiperidine (11.7 g) in light petroleum (15 ml, b.p. 60-80 ° C) was heated on a steam bath. for three hours. The base, which was separated on cooling, was purified by crystallization from aqueous ethanol or from light petroleum (b.p. 60-80 ° C) to form white curly needles with a melting point of 80-81 ° C.

Hydrokloriden kristalliserade ur en blandning av etanol och eter i mycket sma skinande nalar med smaltpunkten 157-159°C. The hydrochloride crystallized from a mixture of ethanol and ether in very small shiny needles, m.p. 157-159 ° C.

Exempel 6. 1-(4'-etoxikarbony1-4'-feny1)-piperidino-3-p-toloxipropan-2-ol. Example 6. 1- (4'-Ethoxycarbonyl-4'-phenyl) -piperidino-3-p-toloxypropan-2-ol.

Till en losning av 4-etoxikarbony1-4-fenylpipe ridin (12,5 g) i 25 ml absolut etanol sattes 10,75 g 2-hydroxi-3-p-toloxipropylklorid och darefter 2,85 g vattenfritt natriumkarbonat. Blandningen upphettades pa angbad under aterflode i fern timmar. Den kyldes, utspaddes val med vatten och den gurnmiartade oljan extraherades med kloroform. Kloroformextraktet tvattades med vatten och kloroformen avdestillerades. Den aterstaende oljan stelnade hastigt. Den renades genom kristallisering ur en blandning av etanol och lattpetroleum (kokpunkt 60-80°C) eller ur vattenhaltig etanol, varvid basen erholls som vita krusiga nalar med smaltpunkten 111-113°C. Hydrokloriden kristalliserade ur en blandning av etanol och eter i smâ vita nalar med smaltpunkten 152-154°C. To a solution of 4-ethoxycarbonyl-4-phenylpiperidine (12.5 g) in 25 ml of absolute ethanol was added 10.75 g of 2-hydroxy-3-p-toloxypropyl chloride and then 2.85 g of anhydrous sodium carbonate. The mixture was heated on a steam bath under reflux for four hours. It was cooled, diluted with water and the gourmet oil was extracted with chloroform. The chloroform extract was washed with water and the chloroform was distilled off. The remaining oil solidified rapidly. It was purified by crystallization from a mixture of ethanol and light petroleum (b.p. 60-80 ° C) or from aqueous ethanol to give the base as white curly needles, m.p. 111-113 ° C. The hydrochloride crystallized from a mixture of ethanol and ether in small white needles, m.p. 152-154 ° C.

Exempel 7. 1-(4'-etoxikarbony1-4'-feny1)-piperidino-3-p-etoxikarbonylfenoxi-propan-2-ol. 3-p-etoxikarbonylfenoxi-1:2-epoxipropan (9,6 g) sattes till en %suing av 4-etoxikarbony1-4-fenylpiperidin i =petroleum (20 ml, kokpunkt 6080°C) och blandningen upphettades pa angbad i 3 timmar. Basen stelnade vid kylning. Den kristalliserade ur en blandning av etanol och petroleum (kokpunkt 60-80°C) i vita krusiga nalar, smaltpunkt 86-88°C. Example 7. 1- (4'-Ethoxycarbonyl-4'-phenyl) -piperidino-3-p-ethoxycarbonylphenoxy-propan-2-ol. 3-β-Ethoxycarbonylphenoxy-1: 2-epoxypropane (9.6 g) was added to a% solution of 4-ethoxycarbonyl-4-phenylpiperidine in petroleum (20 ml, b.p. 6080 ° C) and the mixture was heated on a steam bath for 3 hours . The base solidified on cooling. It crystallized from a mixture of ethanol and petroleum (b.p. 60-80 ° C) in white rippled needles, mp 86-88 ° C.

Hydrokloriden utskildes ur en blandning av etanol och eter i sma vita nalar med smaltpunkten 174-176°C. The hydrochloride was separated from a mixture of ethanol and ether into small white needles, m.p. 174-176 ° C.

Exempel 8. 1-(4'-etoxikarbony1-4'-fenylypiperidino-3-o-fluor-fenoxi-propan-2-ol. Example 8. 1- (4'-Ethoxycarbonyl-4'-phenylypiperidino-3-o-fluoro-phenoxy-propan-2-ol.

Denna forening framstalldes genom omsattning av 3-o-fluorfenoxi-1:2-epoxipropan (7,9 g) med 4-etoxikarbony1-4-fenylpiperidin (11 g) i lattpetroleum (20 ml, kokpunkt 60-80°C). This compound was prepared by reacting 3-o-fluorophenoxy-1: 2-epoxypropane (7.9 g) with 4-ethoxycarbonyl-4-phenylpiperidine (11 g) in light petroleum (20 ml, b.p. 60-80 ° C).

Den kristalliserade ur etanol i vita nalar, smaltpunkt 80-81°C. It crystallized from ethanol in white needles, m.p. 80-81 ° C.

Hydrokloriden utskildes ur en blandning av etanol och eter och hade smaltpunkten 159°C. The hydrochloride was separated from a mixture of ethanol and ether and had a melting point of 159 ° C.

Exempel 9. 1-(4'-etmdkarbony1-4'-feny1)-piperidino-3-o-allyl-fenoxipropan-2-ol-hydroklorid. Example 9. 1- (4'-Ethylcarbonyl-4'-phenyl) -piperidino-3-o-allyl-phenoxypropan-2-ol hydrochloride.

Till en losning av 4-etoxikarbony1-4-fenylpiperidin (12,7 g) i lattpetroleum (15 ml, kokpunkt 60-80°C) sattes 3-o-allylfenoxi-1:2-epoxipropan (10,35 g) och blandningen upphettades pa angbad i 2 timmar. To a solution of 4-ethoxycarbonyl- 4-phenylpiperidine (12.7 g) in light petroleum (15 ml, b.p. 60-80 ° C) was added 3-o-allylphenoxy-1: 2-epoxypropane (10.35 g) and the mixture heated on steam bath for 2 hours.

Efter kylning behandlades blandningen med ett litet overskott av etanolisk klorvatesyra. Hydrokloriden utskildes omedelbart och renades genom kristallisering ur 20 -0/0 etanol och bildade sma vita skinande plattor med smaltpunkten 198-200°C. After cooling, the mixture was treated with a small excess of ethanolic hydrochloric acid. The hydrochloride was immediately separated and purified by crystallization from 20 -0/0 ethanol to give small white shiny plates, m.p. 198-200 ° C.

Exempel 10. 1-(4'-etoxikarbony1-4'-feny1)-piperidino-2-metyl-3-o-toloxi-propan-2-ol-hydroklorid. Example 10. 1- (4'-Ethoxycarbonyl-4'-phenyl) -piperidino-2-methyl-3-o-toloxy-propan-2-ol hydrochloride.

En blandning av 3-o-toloxi-2-mety1-1:2-epoxipropan (6,8 g) och 4-etmdkarbony1-4-fenylpiperidin (8,9 g) i =petroleum (20 ml, kokpunkt 60-80°C) upphettades pa angbad i 2 timmar. Efter avlagsnande av lOsningsmedel omvandlades den viskosa aterstoden direkt till hydrokloriden 4 I etanolisk losning. Den renades genom kristallisering ur en blandning av etanol och eter och hade smaltpunkten 177°C. A mixture of 3-o-toloxy-2-methyl-1: 2-epoxypropane (6.8 g) and 4-ethmycarbonyl-4-phenylpiperidine (8.9 g) in petroleum (20 ml, b.p. 60-80 ° C) was heated on a steam bath for 2 hours. After removal of the solvent, the viscous residue was converted directly to the hydrochloride 4 L of ethanolic solution. It was purified by crystallization from a mixture of ethanol and ether and had a melting point of 177 ° C.

Exempel 11. 1-(4'-etoxikarbony1-4'-feny1)-piperidino-3-m-klorfenoxi-propan-2-ol. Example 11. 1- (4'-Ethoxycarbonyl-4'-phenyl) -piperidino-3-m-chlorophenoxy-propan-2-ol.

Denna forening framstalldes genom kondensation av 3-m-klorfenoxi-1:2-epoxipropan (9,25 g) med 4-etoxikarbony1-4-fenylpiperidin (11,7 g) i lattpetroleum (40 ml, kokpunkt 60-80°C). Den kristalliserade ur vattenhaltig etanol i vita nalar, smaltpunkt 89-90°C. This compound was prepared by condensing 3-m-chlorophenoxy-1: 2-epoxypropane (9.25 g) with 4-ethoxycarbonyl-4-phenylpiperidine (11.7 g) in light petroleum (40 ml, b.p. 60-80 ° C) . It crystallized from aqueous ethanol in white needles, m.p. 89-90 ° C.

Hydrokloriden utskildes ur en blandning av etanol och eter och hade smaltpunkten 162163°C. The hydrochloride was separated from a mixture of ethanol and ether and had a melting point of 162163 ° C.

Exempel 12. 1-(4'-etoxikarbony1-4'-feny1)-piperidino-3-p-klorfenoxipropan-2-ol. Example 12. 1- (4'-Ethoxycarbonyl-4'-phenyl) -piperidino-3-p-chlorophenoxypropan-2-ol.

En blandning av 3-p-klorfenoxi-1:2-epoxipropan (8,0 g) och 4-etox.ikarbony1-4-fenylpiperidin (10,0 g) i lattpetroleum (25 ml, kokpunkt 6080°C) varmdes pa angbad i 2 timmar. Produkten utskildes vid svag kylning. Den renades genom kristallisering ur vattenhaltig etanol varvid det erholls vita nhlar med smaltpunkten 103-104°C. A mixture of 3-p-chlorophenoxy-1: 2-epoxypropane (8.0 g) and 4-ethoxycarbonyl-4-phenylpiperidine (10.0 g) in light petroleum (25 ml, boiling point 6080 ° C) was heated on a steam bath. for 2 hours. The product was excreted on slight cooling. It was purified by crystallization from aqueous ethanol to give white nails, m.p. 103-104 ° C.

Hydrokloriden utskildes ur en blandning av etanol och eter i vita nalar med smaltpunkten 165-166°C. The hydrochloride was separated from a mixture of ethanol and ether in white needles, m.p. 165-166 ° C.

Exempel 13. 1-(4'-etoxikarbony1-4'-feny1)-piperidino-3-o-metcudfenoxipropan-2-ol. 3-o-metoxifenoxi-1:2-epoxipropan (9,0 g) sattes till en losning av 4-etoxikarbony1-4-fenylpiperidin (11,7 g) i lattpetroleum (25 ml, kokpunkt 6080°C) innehallande nagra droppar etanol, och blandningen npphettades under aterfltide i 2 tiramar. Den produkt, som utskildes vid kylning, renades genom kristallisering ur vattenhaltig etanol under bildning av vita nalar, smaltpunkt 89-90°C. Example 13. 1- (4'-Ethoxycarbonyl-4'-phenyl) -piperidino-3-o-methcudphenoxypropan-2-ol. 3-o-Methoxyphenoxy-1: 2-epoxypropane (9.0 g) was added to a solution of 4-ethoxycarbonyl-4-phenylpiperidine (11.7 g) in light petroleum (25 ml, b.p. 6080 ° C) containing a few drops of ethanol , and the mixture was heated under reflux for 2 hours. The product, which was separated on cooling, was purified by crystallization from aqueous ethanol to give white needles, m.p. 89-90 ° C.

Hydrokloriden utskildes ur en blandning av etanol och eter i vita nalar med smaltpunkten 147-148°C. The hydrochloride was separated from a mixture of ethanol and ether in white needles, m.p. 147-148 ° C.

Exempel 14. 1-(4'-etoxikarbony1-4'-feny1)-piperidino-2-mety1-3-fenoxipropan-2-ol-hydroklorid. Example 14. 1- (4'-Ethoxycarbonyl-4'-phenyl) -piperidino-2-methyl-3-phenoxypropan-2-ol hydrochloride.

En blandning av 3-fenoxi-2-mety1-1:2-epoxipropan (8,2 g) och 4-etoxikarbony1-4-fenylpiperidin (11,65 g) i lattpetroleum (25 ml, kokpunkt 60-80°C) upphettades pa angbad i 2 tinunar. Efter avlagsnande av losningsmedel omvandlades den oljeartade basen direkt till hydrokloriden i etanolisk losning. Den senare kristalliserade ur en blandning av etanol och eter i vita 'Alm med smaltpunkten 171-172°C. A mixture of 3-phenoxy-2-methyl-1: 2-epoxypropane (8.2 g) and 4-ethoxycarbonyl-4-phenylpiperidine (11.65 g) in light petroleum (25 ml, b.p. 60-80 ° C) was heated pa angbad i 2 tinunar. After removal of solvent, the oily base was converted directly to the hydrochloride in ethanolic solution. The latter crystallized from a mixture of ethanol and ether in white Alm with a melting point of 171-172 ° C.

Beskrivning av forsok. Description of experiment.

Den analgetiska aktiviteten bestamdes hos moss sasom beskrivits av Bianchi och Fran-. ceschini (Brit. J. Pharmacol. 1954, 9, 280). The analgesic activity was determined in moss as described by Bianchi and Fran-. ceschini (Brit. J. Pharmacol. 1954, 9, 280).

Moss injicerades subkutant med var och en av de foreningar som skulle provas och antalet djur i analgesi 30, 60 och 90 min efter administreringen registrerades. 90 moss anvandes for vardera foreningen vid foljande dosnivaer: 1-(4'-etoxikarbony1-4'-fenyl)-piperidino-3-fenoxipropan-2-ol och 1-(4`-etoxikarbony1-4')-piperidino3-fenoxipropan vid 0,195, 0,39, 0,78, 1,56 och 3,12 mg/kg kroppsvikt. Petidin vid 3,12, 6,25, 12,5, 25 och 30 mg/kg kroppsvikt. Moss was injected subcutaneously with each of the compounds to be tested and the number of animals in analgesia 30, 60 and 90 minutes after administration was recorded. 90 moss was used for each compound at the following dose levels: 1- (4'-ethoxycarbonyl-4'-phenyl) -piperidino-3-phenoxypropan-2-ol and 1- (4'-ethoxycarbonyl-4 ') -piperidino-3-phenoxypropane at 0.195, 0.39, 0.78, 1.56 and 3.12 mg / kg body weight. Pethidine at 3.12, 6.25, 12.5, 25 and 30 mg / kg body weight.

Foreningarna anvandes som hydrokloriderna och lostes i destillerat vatten. The compounds were used as the hydrochlorides and dissolved in distilled water.

De injicerade volymerna hollos konstant vid 0,5 m1/20 g kroppsvikt och forsoken genomfOrdes samtidigt med de tre foreningarna som skulle provas. The injected volumes were constantly healed at 0.5 ml / 20 g body weight and the experiments were performed simultaneously with the three compounds to be tested.

Toxicitetsforsok utfordes aven med de tre foreningarna. Toxicity tests are also challenged with the three associations.

Foljande resultat erhollos med hydrokloriderna av 1- (4' - etoxikarb ony1-4'-feny1)-piperidino -3-fenoxiprop an-2-ol \ CO OEt /-0 CH, CHOH CH,—N\ /ph 1-(4`-etoxikarbony1-4`-feny1)- piperidino-3 -fenoxi-propan COOEt \-0 CH, CH2C112-1■T/ \>The following results are obtained with the hydrochlorides of 1- (4 '- ethoxycarbonyl-4'-phenyl) -piperidino-3-phenoxypropan-2-ol \ CO OEt / -O CH, CHOH CH, -N \ / ph 1- ( 4`-ethoxycarbonyl- 4`-phenyl) -piperidino-3-phenoxy-propane COOEt \ -O CH, CH2Cl12-1 ■ T / \>

Claims (4)

Patentanspriik:Patent claim: 1. satt att framstalla 4-fenyl-piperidinderivat med analgetisk verkan, kannetecknat darav, att ett piperidinderivat med formeln C61-1, /COR' \ /\ \N/ omsattes med en lamplig 3-aryloxi-1:2-epoxipropan med den allmanna formeln 11.2 I 0 I/ \ Ar•O•CH,-CCH, i vilka formler Ar betecknar en fenyl-, o-, m- eller p-tolyl-, o-, m- eller p-metoxifenyl- eller lagre alkoxifenylradikal med 1-6 kolatomer i alkwdgruppen, o-, m- eller p-klorfenyl-, o-, m- eller p-bromfenyl, o-, m- eller p-fluorfenyl eller o-, m- eller p-aminofenylradikal eller acylderivat ddrav, R2 betecknar vate eller en metylgrupp och R' betecknar en lagre alkoxi- eller lagre alkylgrupp innehallande 1-3 kolatomer.1. was prepared to produce 4-phenyl-piperidine derivatives having analgesic action, characterized in that a piperidine derivative of the formula C61-1, / COR general formula 11.2 I 0 I / \ Ar • O • CH, -CCH, in which formulas Ar represents a phenyl, o, m or p-tolyl, o-, m- or p-methoxyphenyl or lower alkoxyphenyl radical having 1-6 carbon atoms in the alkyd group, o-, m- or p-chlorophenyl, o-, m- or p-bromophenyl, o-, m- or p-fluorophenyl or o-, m- or p-aminophenyl radical or acyl derivatives hd, R 2 represents vate or a methyl group and R 'represents a lower alkoxy or lower alkyl group containing 1-3 carbon atoms. 2. Satt enligt patentanspraket 1, kannetecknat darav, att klorvdteacceptorn är natriumkarbonat eller natriumhydro)dd.2. A kit according to claim 1, characterized in that the chlorine tea acceptor is sodium carbonate or sodium hydro) dd. 3. Salt enligt patentanspraket 1, kannetecknat darav, att kondensationen av 3-aryloxi-1:2-epoxipropanen med piperidinderivatet genomferes i franvaro av losningsmedel.Salt according to claim 1, characterized in that the condensation of the 3-aryloxy-1: 2-epoxypropane with the piperidine derivative is carried out in the absence of solvent. 4. Salt enligt patentanspraket 1, kannetecknat darav, att kondensationen av 3-aryloxi-1:2-epoxipropanen med piperidinderivatet genomfores i narvaro av etanol, bensen eller lattpetroleum. AnfOrda publikationer: Patentskrifter fran Sverige 166 674; USA. 2 508 653, 2 498 430.Salt according to claim 1, characterized in that the condensation of the 3-aryloxy-1: 2-epoxypropane with the piperidine derivative is carried out in the presence of ethanol, benzene or lathe petroleum. Cited publications: Patents from Sweden 166,674; USA. 2,508,653, 2,498,430.
SE203478D SE203478C1 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
SE203478T

Publications (1)

Publication Number Publication Date
SE203478C1 true SE203478C1 (en) 1965-01-01

Family

ID=41987223

Family Applications (1)

Application Number Title Priority Date Filing Date
SE203478D SE203478C1 (en)

Country Status (1)

Country Link
SE (1) SE203478C1 (en)

Similar Documents

Publication Publication Date Title
US4476136A (en) Aminomethyl-5 oxazolidinic derivatives and therapeutic use thereof
NO165070B (en) ANALOGUE PROCEDURE FOR THE PREPARATION OF THERAPEUTIC ACTIVE TETRAHYDROBENZTIAZOLES.
US3974158A (en) 2-(Substituted anilino)methylmorpholines
SE451017B (en) CINNAMYLMORANOLIN DERIVATIVES
US2915523A (en) Benzacridine compounds
IE912492A1 (en) 1,4-disubstituted piperazines
US2485550A (en) Quaternary salts of carbamic acid esters of tertiary-hydroxybenzyl-amines
US5688820A (en) Aminoalkyl benzoxazolinones and benzothiazolinones
US3557127A (en) Substituted cyclohexenes,derivatives thereof and processes for obtaining same
DK174505B1 (en) Benzene derivatives and processes for their preparation as well as pharmaceutical agents containing the derivatives
US2794810A (en) Aminoalkyl cycloalkylcarbamates
US3969409A (en) 3-Anilino-5,5-disubstituted-2-aminomethyl-2-cyclohexen-1-ones and the salts thereof
Rokach et al. Cyclic amidine inhibitors of indolamine N-methyltransferase
NO162154B (en) ANALOGUE PROCEDURE FOR THE PREPARATION OF URE ADDITIVES.
SE203478C1 (en)
US2470108A (en) Heterocyclic amines
FI61484B (en) PROCEDURE FOR FRAMSTATION OF Z-3- (4-BROMOPHENYL) -N-METHYL-3- (3-PYRIDYL) -ALLYLAMINE WITH ANTIDEPRESSIVE OCH
SE435927B (en) TRANS-4- (2-CHLOROPHENOXY) -1-ETHYL-PYRROLIDINOL WITH THERAPEUTIC EFFECT
EP0230020A2 (en) 1,2,3,4,4a,9b-Hexahydro-4a-aminoalkyldibenzofurans, a process for their preparation and their use as medicaments
US3850947A (en) 3-thiazol-4'-oxy-aminopropanol cardiovascular agents
US2865925A (en) Process for preparing n-(2-hydroxyethyl)-n-(lower-alkyl)-9-aminomethylanthracenes and intermediates therein
US4029786A (en) Morpholine derivatives for treating depression
PL82037B1 (en)
US4333930A (en) Orthoarylideneaminophenethylamines and pharmaceutical compositions
US3184452A (en) New aminoalkoxy compounds and process for theik manufacture